HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew G Digiovanni Selected Research

MDC-1112

1/2020Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew G Digiovanni Research Topics

Disease

1Neoplasms (Cancer)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

1MDC-1112IBA
01/2020
1GemcitabineFDA Link
01/2020
1Valproic Acid (Depakote)FDA LinkGeneric
01/2020